Literature DB >> 2981633

Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma.

L M Corcoran, S Cory, J M Adams.   

Abstract

A novel mechanism of oncogene activation by transposition of a tissue-specific cellular enhancer is described. A rearranged c-myc oncogene was cloned from murine plasmacytoma ABPC17 in the expectation that it would reflect the t(6;15) chromosome translocation carried by this tumor. The rearrangement instead reflects an insertion 361 bp 5' to the c-myc gene on chromosome 15. The insert conveys a 2.3 kb segment of the immunoglobulin heavy (H) chain locus from chromosome 12. Since the insertion introduces the lymphoid-specific enhancer from the JH-Smu region and also disrupts a region implicated in normal c-myc control, it may account for the c-myc transcription observed in ABPC17. The structure of the transposed segment and a corresponding deletion in the JH-Smu region suggests that the transposition reflects a complex recombination between chromosomes 15 and 12. Since the t(6;15) breakpoint is not near c-myc, chromosome 15 must have undergone an independent exchange with chromosome 6.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981633     DOI: 10.1016/0092-8674(85)90310-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  35 in total

1.  Transient expression of a winged-helix protein, MNF-beta, during myogenesis.

Authors:  Q Yang; R Bassel-Duby; R S Williams
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  The PKZ1 recombination mutation assay: a sensitive assay for low dose studies.

Authors:  P J Sykes; A A Morley; A M Hooker
Journal:  Dose Response       Date:  2006-08-19       Impact factor: 2.658

3.  DNA sequence analysis of the genetic recombination between Igh6 and Myc in an uncommon BALB/c plasmacytoma, TEPC 1194.

Authors:  A L Kovalchuk; M Potter; S Janz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene.

Authors:  M Lipp; R Schilling; S Wiest; G Laux; G W Bornkamm
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

5.  cis-acting translational effects of the 5' noncoding region of c-myc mRNA.

Authors:  N Parkin; A Darveau; R Nicholson; N Sonenberg
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

6.  Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter.

Authors:  E Kakkis; M Mercola; K Calame
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

7.  Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.

Authors:  P D Fahrlander; J Sümegi; J Q Yang; F Wiener; K B Marcu; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  An active chromatin structure acquired by translocated c-myc genes.

Authors:  E Kakkis; J Prehn; K Calame
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

9.  Discovery platform for inhibitors of IgH gene enhancer activity.

Authors:  Nathan G Dolloff
Journal:  Cancer Biol Ther       Date:  2018-11-27       Impact factor: 4.742

10.  Analysis of the promoter of the cytochrome P-450 2B2 gene in the rat.

Authors:  M Hoffmann; W H Mager; B J Scholte; A Civil; R J Planta
Journal:  Gene Expr       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.